Breast Cancer
Conference Coverage
Add-on agents boost neoadjuvant chemo response in triple-negative disease
Major finding: Carboplatin improved the odds of pCR by 71%-76% with some additional toxicity; bevacizumab improved the odds of pCR by 58% with...
News
Meeting attendees identify top studies presented at SABCS
Video
'Vogl, New York' offers San Antonio perspectives
Conference Coverage
Veliparib-carboplatin combo is first 'graduate' of I-SPY2 trial
Major finding: Among patients with triple-negative disease, there was a 90% predictive probability that veliparib-carboplatin added to...
News
New mega-review underscores mammography’s benefits
News
No survival benefit to bisphosphonate in chemoresistant breast cancer
Conference Coverage
Exercise dampens aromatase inhibitor–related joint pain
Major finding: Breast cancer patients experienced a 30% reduction in aromatase inhibitor–related joint pain, with pain scores going from moderate...
News
SABCS Roundtable with Dr. Howard Burris and Dr. William Gradishar
News
Surgery adds little after successful chemo in metastatic breast cancer
News
No gain seen from adjuvant bevacizumab in HER2-positive disease
Major Finding: The rate of invasive disease–free survival did not differ significantly between patients on bevacizumab and those who were not (92...
News
IBIS-II: Anastrozole highly effective in preventing breast cancer
Major finding: The 7-year cumulative incidence of all breast cancers in high-risk postmenopausal women who took anastrozole once daily for 5 years...